article · Babcock University Medical Journal
Objective: Major efforts are being made to curtail the spread and adverse effects of the coronavirus pandemic using vaccines. Ever since vaccines have become available, there has been a global effort to attain herd immunity of at least 75% through the administration of vaccines. There is a dire need to assess the knowledge as well as the acceptability of COVID-19 vaccines among residents of Jos South Local Government. This study aims to assess the knowledge and acceptability of the COVID-19 vaccine among residents of Jos South Local Government. Methodology: It was a descriptive cross-sectional study, 318 respondents were selected using a multistage sampling technique, with a 98.7% response rate. Data were collected using an interviewer-administered semi-structured questionnaire and analyzed using IBM SPSS version 25. Frequency tables were drawn from univariate analysis and Chi-square was used to test for association between two categorical variables. The level of significance is set at P<0.05. Result: This study revealed that 50.6% of respondents have good knowledge of the COVID-19 vaccine, while 70.8% have good acceptability of the COVID-19 vaccine, 66.0% were already vaccinated, a significant association was found between age and COVID-19 vaccine acceptability among respondents at (ꭓ2=9.495, p=0.045). Conclusion: The level of acceptance of the COVID-19 vaccine was moderately high among the participants, more than two-thirds of the respondents had good knowledge and acceptability of the COVID-19 vaccine. Therefore, the need for more health-related education among the general populace to alleviate any fears associated with the vaccine is urgently required.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.38029/babcockuniv.med.j..v7i2.382
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.